The effect of ATP analogues on the spontaneous electrical and mechanical activity of rat portal vein longitudinal muscle.
The effects of ATP (30-1,000 microM) and four of its structural analogues 2-methylthio ATP (30-1,000 microM), beta,gamma-methylene ATP (30-1,000 microM) (beta,gamma-MeATP), L-beta,gamma-methylene ATP (1-100 microM) (L-beta,gamma-MeATP) and alpha,beta-methylene ATP (0.3-100 microM) (alpha,beta-MeATP) were studied on the spontaneous electrical and mechanical activity of the longitudinal muscle of the rat portal vein using the sucrose gap apparatus. Portal vein preparations displayed spontaneous activity in which slow depolarizations led to bursts of spikes which were concomitant with rhythmic contractions. Low concentrations of ATP analogues initiated an increased frequency of the regular spontaneous waves of depolarizations and contractions. Higher concentrations caused an increased frequency of action potential firing, a sustained depolarization and contraction. The rank order of agonist potency for both contractile and electrophysiological responses was found to be alpha,beta-MeATP greater than L-beta,gamma-MeATP greater than beta,gamma-MeATP greater than 2-methylthio ATP greater than ATP. Prolonged superfusion with alpha,beta-MeATP (10 microM) led to desensitization of P2-purinoceptors so that responses to the other ATP analogues were blocked while responses to noradrenaline were unaffected. On the basis of the rank order of agonist potencies and desensitization with alpha,beta-MeATP, the P2-purinoceptors mediating contraction of the longitudinal muscle of the rat portal vein are classified as being of the P2X-subtype.
D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D066298:In Vitro Techniques; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011169:Portal Vein / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D011983:Receptors, Purinergic / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
D011983:Receptors, Purinergic; D000255:Adenosine Triphosphate